France Ruminant Vaccines Market Size & Outlook, 2023-2030

The ruminant vaccines market in France is expected to reach a projected revenue of US$ 296.8 million by 2030. A compound annual growth rate of 7.4% is expected of France ruminant vaccines market from 2024 to 2030.
Revenue, 2023 (US$M)
$180.1
Forecast, 2030 (US$M)
$296.8
CAGR, 2024 - 2030
7.4%
Report Coverage
France

France ruminant vaccines market highlights

  • The France ruminant vaccines market generated a revenue of USD 180.1 million in 2023 and is expected to reach USD 296.8 million by 2030.
  • The France market is expected to grow at a CAGR of 7.4% from 2024 to 2030.
  • In terms of segment, modified/ attenuated live was the largest revenue generating vaccine type in 2023.
  • Other Vaccines is the most lucrative vaccine type segment registering the fastest growth during the forecast period.

Ruminant vaccines market data book summary

Market revenue in 2023USD 180.1 million
Market revenue in 2030USD 296.8 million
Growth rate7.4% (CAGR from 2023 to 2030)
Largest segmentModified/ attenuated live
Fastest growing segmentOther Vaccines
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationModified/ Attenuated Live, Inactivated (Killed), Other Vaccines
Key market players worldwideBoehringer Ingelheim, Zoetis, Merck & Co Inc, Indian Immunologicals, Elanco Animal Health Inc, Virbac SA, Ceva Santé Animale

Other key industry trends

  • In terms of revenue, France accounted for 5.2% of the global ruminant vaccines market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany ruminant vaccines market is projected to lead the regional market in terms of revenue in 2030.
  • Denmark is the fastest growing regional market in Europe and is projected to reach USD 15.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Ruminant Vaccines Market Scope

Ruminant vaccines market segmentation & scope
Modified/ Attenuated Live
Inactivated (Killed)
Other Vaccines
Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids)
Injectable
Others (e.g. Intranasal)
Others (e.g. Oral, Intranasal)
Others (e.g. Oral, Oculo-nasal etc.)
Others (e.g. Immersion & Spray, Oral)

Ruminant Vaccines Market Companies

Name Profile # Employees HQ Website

France ruminant vaccines market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ruminant vaccines market will help companies and investors design strategic landscapes.


Modified/ attenuated live was the largest segment with a revenue share of 52.47% in 2023. Horizon Databook has segmented the France ruminant vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.


  • France Ruminant Vaccines Vaccine Type Outlook (Revenue, USD Million, 2018-2030)
    • Modified/ Attenuated Live
    • Inactivated (Killed)
    • Other Vaccines
    • Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids)
  • France Ruminant Vaccines Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Injectable
    • Others (e.g. Intranasal)
    • Others (e.g. Oral, Intranasal)
    • Others (e.g. Oral, Oculo-nasal etc.)
    • Others (e.g. Immersion & Spray, Oral)

Reasons to subscribe to France ruminant vaccines market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France ruminant vaccines market databook

  • Our clientele includes a mix of ruminant vaccines market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France ruminant vaccines market , including forecasts for subscribers. This country databook contains high-level insights into France ruminant vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France ruminant vaccines market size, by vaccine type, 2018-2030 (US$M)

France Ruminant Vaccines Market Outlook Share, 2023 & 2030 (US$M)

France ruminant vaccines market size, by vaccine type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more